Rich Pharmaceuticals, Inc. Note Agreements

47 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and SD Law Group APC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2019
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and Richard L. Chang Holdings, LLC (June 19, 2019)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2019
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC dated March 15, 2018
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2018
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2018
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC (November 3, 2017)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC dated April 18, 2017
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC (February 21, 2017)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Promissory Note between Rich Pharmaceuticals, Inc. and GHS Investments, LLC dated February 21, 2017
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NV
2017
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and GHS Investments, LLC dated February 22, 2017
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Promissory Note between Rich Pharmaceuticals, Inc. and GHS Investments, LLC dated February 21, 2017
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NV
2017
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and GHS Investments, LLC dated February 20, 2017
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC (January 5, 2017)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due October 20, 2017 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Affidavit of Confession of Judgment between LG Capital Funding, LLC and Rich Pharmaceuticals, Inc.
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Collateralized Secured Promissory Note between LG Capital Funding, LLC and Rich Pharmaceuticals, Inc. dated June 23, 2016
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due June 23, 2017 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due June 23, 2017 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Collateralized Secured Promissory Note between LG Capital Funding, LLC and Rich Pharmaceuticals, Inc. dated June 8, 2016
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due June 8, 2017 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due June 8, 2017 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Secured Promissory Note between Company and Computerlaw Group LLP dated May 31, 2016
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Secured Investor Note #1 between Typenex Co-Investment, LLC and Rich Pharmaceuticals, Inc. dated May 27, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
UT
2015
Secured Convertible Promissory Note between Rich Pharmaceuticals, Inc. and Typenex Co-Investment, LLC dated May 27, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
UT
2015
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and Vis Vires Group, Inc. dated May 6, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Collateralized Secured Promissory Note between LG Capital Funding, LLC and Rich Pharmaceuticals, Inc. dated May 5, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due May 5, 2016 (with LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due May 5, 2016 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Collateralized Secured Promissory Note between Adar Bays, LLC and Rich Pharmaceuticals, Inc. dated March 26, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note with Adar Bays, LLC (Due March 26, 2016)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due March 26, 2016 (Adar Bays, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and Auctus Private Equity Fund, LLC dated March 9, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
MA
2015
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and KBM Worldwide, Inc. dated February 5, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and KBM Worldwide, Inc. dated January 9, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and KBM Worldwide, Inc. dated November 25, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and KBM Worldwide, Inc. dated October 6, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
12% Convertible Note Agreement between Rich Pharmaceuticals, Inc. and JSJ Investments Inc. dated November 6, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
TX
2014
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and Auctus Private Equity Fund, LLC dated September 23, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
MA
2014
Master Convertible Promissory Note between Rich Pharmaceuticals, Inc. and Typenex Co-Investment, LLC (September 18, 2014)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and KBM Worldwide, Inc. dated May 21, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and KBM Worldwide, Inc. dated April 8, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014